glucose, (beta-d)-isomer has been researched along with Dermatitis Medicamentosa in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (20.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 2 (40.00) | 2.80 |
Authors | Studies |
---|---|
Brain, SD; Greenacre, SA; Halliwell, B; Meinerikandathevan, S; Poston, RN; Rawlingson, A; Rocha, FA; Ruiz, E | 1 |
Fujiyata, T; Kato, T; Kuramoto, Y; Terui, T | 1 |
Auguste, BL; Poon, S; Yau, K | 2 |
Nakamura, M; Nishio, D; Saito-Sasaki, N; Sawada, Y | 1 |
1 review(s) available for glucose, (beta-d)-isomer and Dermatitis Medicamentosa
Article | Year |
---|---|
First case of drug eruption due to ipragliflozin: Case report and review of the literature.
Topics: Aged; Diabetes Mellitus; Drug Eruptions; Glucosides; Humans; Hypoglycemic Agents; Male; Thiophenes | 2017 |
4 other study(ies) available for glucose, (beta-d)-isomer and Dermatitis Medicamentosa
Article | Year |
---|---|
Protein nitration in cutaneous inflammation in the rat: essential role of inducible nitric oxide synthase and polymorphonuclear leukocytes.
Topics: Analysis of Variance; Animals; Blotting, Western; Drug Eruptions; Enzyme Induction; Enzyme-Linked Immunosorbent Assay; Immunohistochemistry; Male; Molecular Weight; Neutrophils; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Proteins; Rats; Rats, Wistar; Skin; Zymosan | 2002 |
Suppression of zymosan-induced chemiluminescence of whole blood by conjugates composed of drug, guinea pig skin extracts and sera from patients with suspicious drug eruptions.
Topics: Animals; Antigen-Antibody Complex; Blood; Drug Eruptions; Granulocytes; Guinea Pigs; Humans; Luminescent Measurements; Skin; Tissue Extracts; Zymosan | 1983 |
Drug eruption associated with empagliflozin.
Topics: Benzhydryl Compounds; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Drug Eruptions; Drug Therapy, Combination; Glucosides; Humans; Hypoglycemic Agents; Treatment Outcome | 2022 |
Topics: Benzhydryl Compounds; Drug Eruptions; Exanthema; Glucosides; Humans | 2023 |